{"id":37155,"date":"2020-07-08T09:51:01","date_gmt":"2020-07-08T07:51:01","guid":{"rendered":"https:\/\/www.aiom.it\/?p=37155"},"modified":"2020-07-08T09:51:01","modified_gmt":"2020-07-08T07:51:01","slug":"atezolizumab-vemurafenib-and-cobimetinib-as-first-line-treatment-for-unresectable-advanced-brafv600-mutation-positive-melanoma-imspire150-primary-analysis-of-the-randomised-double-blind-placebo","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/atezolizumab-vemurafenib-and-cobimetinib-as-first-line-treatment-for-unresectable-advanced-brafv600-mutation-positive-melanoma-imspire150-primary-analysis-of-the-randomised-double-blind-placebo\/","title":{"rendered":"Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial"},"content":{"rendered":"<p><em>Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Georgy Moiseevich Manikhas, Yibing Yan, Kuan-Chieh Huang, Anne Uyei, Virginia McNally, Grant A McArthur, Paolo A Ascierto <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-37149\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/07\/TheLancet-223x300.png\" alt=\"\" width=\"223\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/07\/TheLancet-223x300.png 223w, https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/07\/TheLancet.png 572w\" sizes=\"auto, (max-width: 223px) 100vw, 223px\" \/><\/em><\/p>\n<p><em>The Lancet, 2020 Jun 13<\/em><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32534646\/\">Abstract Link<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Georgy Moiseevich Manikhas, Yibing Yan, Kuan-Chieh Huang, Anne Uyei, Virginia McNally, Grant A McArthur, Paolo A Ascierto The Lancet, 2020 Jun 13 &nbsp; Abstract Link<\/p>\n","protected":false},"author":11,"featured_media":37152,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[],"class_list":["post-37155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/37155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=37155"}],"version-history":[{"count":2,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/37155\/revisions"}],"predecessor-version":[{"id":37157,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/37155\/revisions\/37157"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/37152"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=37155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=37155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=37155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}